CARTHAGE, Mo. - TelAve -- Stratum Nutrition®, (a business of ESM Technologies), and Adare Biome™, (a division of Adare Pharma Solutions) have entered into a value-added distribution agreement for LBiome™, a unique postbiotic composed of 2 human-origin strains that have been heat-stabilized with its culture medium. LBiome™, also known as Lactobacillus LB, has been used as a digestive health solution for over a century. This alliance adds strategic value for both companies within the dietary supplement marketplace.

Researched in postbiotic form for over 100 years, LBiome™ is the "Pioneer in Postbiotics", with 18 published clinical studies showing digestive health support for both adult and pediatric populations. LBiome™ provides the digestive benefits of a probiotic and the formulation flexibility of a spore, with none of the stability or manufacturing concerns.

Studies have shown that LBiome™ cells adhere to intestinal epithelial cells (the type of cells that line the gut) and strengthen the connections (tight junctions) between these cells. LBiome™ has been shown to rapidly calm lower GI upset as evidenced in the many published clinical studies that have demonstrated the beneficial effects of LBiome™.

More on TelAve News

• 3E Launches First AI Agent Designed to Respond with Empathy for College Recruitment
• Security Alert: TZNXG Warns Investors About "Fund Recovery" Scams
• Assent Unveils Extended Producer Responsibility Packaging Solution to Simplify Compliance with Expanding Packaging Laws
• KatalisCoin: "Too Secure" for Bad Actors - Platform Embraces "Excessive Compliance" Criticism
• Keyanb Exchange Implements Enhanced Security Protocols Amid Industry-Wide Trust Challenges

"Postbiotics are an emerging category of biotics in the microbiome space, having shown very interesting properties and benefits in which Adare Biome has an expertise as an organization in that area", said Frederic Appert, Vice President & Business Unit Leader at Adare Biome. "We are excited to be partnering with Stratum Nutrition to make our technology available in the US dietary supplement market."

Micah Osborne, President of Stratum Nutrition said, "It is exciting to enter the digestive health category by bringing a unique ingredient for gut health into Stratum's highly selective portfolio. As more customers want alternative delivery options with human-derived strains, we see big opportunities for this health category and look forward to sharing with the industry the efficacy and flexibility of the postbiotic ingredient, LBiome™. It is an honor to partner with Adare, a company with a legacy of developing and manufacturing innovative products of the highest integrity."

For more information about Stratum Nutrition and its branded ingredients, please email info@StratumNutrition.com.

###

About Stratum Nutrition
Stratum Nutrition®, a business of ESM Technologies, LLC, is a trusted ingredient innovator supplying unique, world-class nutrition ingredients and delivery technologies to product formulators for human and pet health. Stratum offers a portfolio of research-supported ingredients that stand out in their respective health categories as being progressive, safe, and effective, including NEM® brand eggshell membrane, LBiome™ Lactobacillus LB postbiotic, Ahiflower®, BLIS K12™, BLIS M18™, Nataxtin™ astaxanthin, Curcumin 95, and ESC® brand eggshell calcium. These trusted ingredients are relied upon by consumers internationally. Visit www.stratumnutrition.com for more information.

More on TelAve News

• TSWHZC Platform Combines Automated Portfolio Management with Proof of Reserves for Brazil Market Entry
• AureaVault Positions Digital Asset Infrastructure for Shifting Monetary Policy Environment
• JQRBT Unveils High-Speed Trading Infrastructure Designed for Growing Institutional Crypto Market
• New Leadership and Renovations Usher in Next Chapter for Sunrise Manor
• Who Will Win the 2025 WNBA Finals? OddsTrader Shares Live Betting Odds and Projections

About Adare Biome
Adare Biome is a division of Adare Pharma Solutions focused on postbiotic production through a proprietary ECHO™ fermentation process.  Adare Biome operates from Houdan, France, a GMP Drug facility for microbial fermentation.  Adare Biome's activity is to develop, produce, and commercialize microbiological products including its pharmaceutical product Lactéol™, and its ingredient for digestive health applications, LBiome™.   Adare Pharma Solutions is a leading specialty contract development and manufacturing organization (CDMO) and a leading global provider of advanced pharmaceutical technologies, development, and manufacturing. To learn more visit www.adarepharmasolutions.com.